27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ethnopharmacological Approaches for Therapy of Jaundice: Part I

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Jaundice is a very common symptom especially in the developing countries. It is associated with several hepatic diseases which are still major causes of death. There are many different approaches to jaundice treatment and the growing number of ethnomedicinal studies shows the plant pharmacology as very promising direction. Many medicinal plants are used for the treatment of jaundice, however a comprehensive review on this subject has not been published. The use of medicinal plants in drug discovery is highly emphasized (based on their traditional and safe uses in different folk medicine systems from ancient times). Many sophisticated analytical techniques are emerging in the pharmaceutical field to validate and discover new biologically active chemical entities derived from plants. Here, we aim to classify and categorize medicinal plants relevant for the treatment of jaundice according to their origin, geographical location, and usage. Our search included various databases like Pubmed, ScienceDirect, Google Scholar. Keywords and phrases used for these searches included: “jaundice,” “hyperbilirubinemia,” “serum glutamate,” “bilirubin,” “Ayurveda.” The first part of the review focuses on the variety of medicinal plant used for the treatment of jaundice (a total of 207 medicinal plants). In the second part, possible mechanisms of action of biologically active secondary metabolites of plants from five families for jaundice treatment are discussed.

          Related collections

          Most cited references144

          • Record: found
          • Abstract: found
          • Article: not found

          Biliary atresia.

          Biliary atresia is a rare disease of infancy, which has changed within 30 years from being fatal to being a disorder for which effective palliative surgery or curative liver transplantation, or both, are available. Good outcomes for infants depend on early referral and timely Kasai portoenterostomy, and thus a high index of suspicion is needed for investigation of infants with persistent jaundice. In centres with much experience of treating this disorder, up to 60% of children will achieve biliary drainage after Kasai portoenterostomy and will have serum bilirubin within the normal range within 6 months. 80% of children who attain satisfactory biliary drainage will reach adolescence with a good quality of life without undergoing liver transplantation. Although much is known about management of biliary atresia, many aspects are poorly understood, including its pathogenesis. Several hypotheses exist, implicating genetic predisposition and dysregulation of immunity, but the cause is probably multifactorial, with obliterative extrahepatic cholangiopathy as the common endpoint. Researchers are focused on identification of relevant genetic and immune factors and understanding serum and hepatic factors that drive liver fibrosis after Kasai portoenterostomy. These factors might become therapeutic targets to halt the inevitable development of cirrhosis and need for liver transplantation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Medicinal plants of the caatinga (semi-arid) vegetation of NE Brazil: a quantitative approach.

            The caatinga (semi-arid vegetation) is a Brazilian biome with a significant but poorly studied biodiversity closely associated with a diverse cultural heritage. The present work focused on analyzing published information available concerning medicinal plants used by traditional communities. We sought to contribute to future phytochemical and pharmacological investigations by documenting the therapeutic uses of native caatinga plants within the aims of modern ethnopharmacological research. Twenty-one published works cited a total of 389 plant species used by indigenous and rural communities in northeastern Brazil for medicinal purposes. The relative importance index (RI) of each species in these inventories was calculated, and information concerning the plant's local status (spontaneous or cultivated), distribution, and habit was recorded. Of the 275 spontaneous (non-cultivated) species cited, 15.3% were endemic to the caatinga. A statistical relationship was verified between the relative importance of the species and their endemic status (p<0.05). Herbaceous plants were more numerous (169) than trees (90) or shrubs and sub-shrubs (130) at a statistically significant level (p<0.05). A survey of published information on the phytochemical and pharmacological status of the plants demonstrating the highest RI supported the veracity of their attributed folk uses.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

              A specific assay has been developed for a blood-borne non-A, non-B hepatitis (NANBH) virus in which a polypeptide synthesized in recombinant yeast clones of the hepatitis C virus (HCV) is used to capture circulating viral antibodies. HCV antibodies were detected in six of seven human sera that were shown previously to transmit NANBH to chimpanzees. Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses. About 80 percent of chronic, post-transfusion NANBH (PT-NANBH) patients from Italy and Japan had circulating HCV antibody; a much lower frequency (15 percent) was observed in acute, resolving infections. In addition, 58 percent of NANBH patients from the United States with no identifiable source of parenteral exposure to the virus were also positive for HCV antibody. These data indicate that HCV is a major cause of NANBH throughout the world.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                15 August 2017
                2017
                : 8
                : 518
                Affiliations
                [1] 1Department of Pharmaceutical Sciences, Faculty of Technology, Kumaun University Nainital, India
                [2] 2Department of Pharmaceutical Botany, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania
                [3] 3ICHAT and Institute for Life Sciences, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca Cluj-Napoca, Romania
                [4] 4Division BIOCEV, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic Prague, Czechia
                [5] 5Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences Tehran, Iran
                [6] 6Institute of Genetics and Animal Breeding of the Polish Academy of Sciences Jastrzebiec, Poland
                [7] 7School of Medical Sciences, Universiti Sains Malaysia Kota Bharu, Malaysia
                [8] 8Department of Public Health, Xi'an Jiaotong-Liverpool University Suzhou, China
                [9] 9Department of Pharmacognosy, University of Vienna Vienna, Austria
                [10] 10Department of Vascular Biology and Thrombosis Research, Centre for Physiology and Pharmacology, Medical University of Vienna Vienna, Austria
                Author notes

                Edited by: Kalin Yanbo Zhang, University of Hong Kong, Hong Kong

                Reviewed by: Gokhan Zengin, Selçuk University, Turkey; Armando Caceres, University of San Carlos of Guatemala, Guatemala

                *Correspondence: Atanas G. Atanasov a.atanasov.mailbox@ 123456gmail.com

                This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

                †These authors have contributed equally to this work.

                Article
                10.3389/fphar.2017.00518
                5559545
                9d47b458-37bf-4a3a-a51e-a3b1f1827b56
                Copyright © 2017 Tewari, Mocan, Parvanov, Sah, Nabavi, Huminiecki, Ma, Lee, Horbańczuk and Atanasov.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 17 February 2017
                : 24 July 2017
                Page count
                Figures: 3, Tables: 1, Equations: 0, References: 156, Pages: 18, Words: 13645
                Funding
                Funded by: Krajowy Naukowy Osrodek Wiodacy 10.13039/501100008648
                Award ID: No. 05-1/KNOW2/2015
                Categories
                Pharmacology
                Review

                Pharmacology & Pharmaceutical medicine
                jaundice,bilirubin,medicinal plants,ethnopharmacology,traditional use,metalloporphyrin

                Comments

                Comment on this article